The congress will bring together experts in the field of basic and clinical oncology as well as molecular pathology to discuss current issues in cancer treatment decision-making, limitations of diagnostic tools and explore technological solutions to resolve cancer heterogeneity. Considering the previous experience in Verona in 2016, we expect stimulating discussion thanks to the high-level scientific debate and the standing of internationally renowned speakers and attendees.